News Zeposia Approved for Moderately to Severely Active Ulcerative Colitis Publish Date June 1, 2021 The FDA has approved Zeposia® (ozanimod) for moderately to severely active ulcerative colitis in adults.
Drugs in the Pipeline Dupilumab Under Review for Pediatric Asthma Publish Date March 4, 2021 The submission was based on data from the double-blind, placebo-controlled VOYAGE trial.